4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-25-032884
Options or other derivatives
- Chief Financial Officer acquired 175,475 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Harmon Seth Chief Financial Officer | 2025-03-03 | Grant or award · Stock Option (Right to Buy) | +150,407 | 150,407 | D | ||
| Harmon Seth Chief Financial Officer | 2025-03-03 | Grant or award · Restricted Stock Units | +25,068 | 25,068 | D | ||
Loading xslF345X05/ownership.xml…